Waïsse Waïssi

Radiosensitizing Pancreatic Cancer with PARP Inhibitor and Gemcitabine: An In Vivo and a Whole-Transcriptome Analysis after Proton or Photon Irradiation

Waïsse Waïssi, Anaïs Nicol, Matthieu Jung et al. · Cancers · 2021 · 20 citations · Full text

Long-term outcomes after definitive radiotherapy with modern techniques for unresectable soft tissue sarcoma

Benoît Allignet, Waïsse Waïssi, Xavier Geets et al. · Radiotherapy and Oncology · 2022 · 18 citations · Full text

Adaptive Radiotherapy, Surgical Oncology, Radiation Therapy +8

Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines

Waïsse Waïssi, Jean‐Christophe Amé, Carole Mura et al. · International Journal of Molecular Sciences · 2021 · 16 citations · Full text

Parp Inhibitor, Gemcitabine-based Chemoradiotherapy Enhanced, Pathology +17

Impact of histological subtype on radiological and pathological response after neoadjuvant radiotherapy in soft tissue sarcoma

Benoît Allignet, Alexandra Meurgey, Amine Bouhamama et al. · European Journal of Surgical Oncology · 2021 · 15 citations

Surgical Oncology, Radiation Therapy, Soft Tissue Sarcoma +9

Surgery Is an Effective Option after Failure of Chemoradiation in Cancers of the Anal Canal and Anal Margin

Jean‐Baptiste Delhorme, François Séverac, Waïsse Waïssi et al. · Oncology · 2017 · 12 citations